A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: A case study on chemical-induced liver steatosis

被引:9
|
作者
Verhoeven, Anouk [1 ]
van Ertvelde, Jonas [1 ]
Boeckmans, Joost [1 ]
Gatzios, Alexandra [1 ]
Jover, Ramiro [2 ,3 ]
Lindeman, Birgitte [4 ]
Lopez-Soop, Graciela [4 ]
Rodrigues, Robim M. [1 ]
Rapisarda, Anna [2 ,3 ]
Sanz-Serrano, Julen [1 ]
Stinckens, Marth [1 ]
Sepehri, Sara [1 ]
Teunis, Marc [5 ]
Vinken, Mathieu [1 ]
Jiang, Jian [1 ]
Vanhaecke, Tamara [1 ]
机构
[1] Vrije Univ Brussel, Dept Pharmaceut & Pharmacol Sci, Ent Vitro Toxicol & Dermato Cosmetol, Laarbeeklaan 103, B-1090 Brussels, Belgium
[2] Univ Valencia, Hosp La Fe, Joint Res Unit Expt Hepatol, Hlth Res Inst, Valencia, Spain
[3] CIBER Hepat & Digest Dis, Valencia, Spain
[4] Norwegian Inst Publ Hlth, Dept Chem Toxicol, Oslo, Norway
[5] Univ Appl Sci Utrecht, Innovat Testing Life Sci & Chem, Utrecht, Netherlands
基金
欧盟地平线“2020”;
关键词
adverse outcome pathway; steatosis; chemical toxicity; weight-of-evidence; Bradford-Hill criteria; artificial intelligence; HEPATIC STEATOSIS; NUCLEAR RECEPTORS; IDENTIFICATION;
D O I
10.1016/j.tox.2024.153814
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The field of chemical toxicity testing is undergoing a transition to overcome the limitations of in vivo experiments. This evolution involves implementing innovative non-animal approaches to improve predictability and provide a more precise understanding of toxicity mechanisms. Adverse outcome pathway (AOP) networks are pivotal in organizing existing mechanistic knowledge related to toxicological processes. However, these AOP networks are dynamic and require regular updates to incorporate the latest data. Regulatory challenges also persist due to concerns about the reliability of the information they offer. This study introduces a generic Weightof-Evidence (WoE) scoring method, aligned with the tailored Bradford-Hill criteria, to quantitatively assess the confidence levels in key event relationships (KERs) within AOP networks. We use the previously published AOP network on chemical-induced liver steatosis, a prevalent form of human liver injury, as a case study. Initially, the existing AOP network is optimized with the latest scientific information extracted from PubMed using the free SysRev platform for artificial intelligence (AI)-based abstract inclusion and standardized data collection. The resulting optimized AOP network, constructed using Cytoscape, visually represents confidence levels through node size (key event, KE) and edge thickness (KERs). Additionally, a Shiny application is developed to facilitate user interaction with the dataset, promoting future updates. Our analysis of 173 research papers yielded 100 unique KEs and 221 KERs among which 72 KEs and 170 KERs, respectively, have not been previously documented in the prior AOP network or AOP-wiki. Notably, modifications in de novo lipogenesis, fatty acid uptake and mitochondrial beta-oxidation, leading to lipid accumulation and liver steatosis, garnered the highest KER confidence scores. In conclusion, our study delivers a generic methodology for developing and assessing AOP networks. The quantitative WoE scoring method facilitates in determining the level of support for KERs within
引用
收藏
页数:11
相关论文
共 9 条
  • [1] Chemical-induced liver cancer: an adverse outcome pathway perspective
    Sanz-Serrano, Julen
    Callewaert, Ellen
    De Boever, Sybren
    Drees, Annika
    Verhoeven, Anouk
    Vinken, Mathieu
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (04) : 425 - 438
  • [2] An updated adverse outcome pathway network on chemical- induced liver steatosis
    Verhoeven, A.
    van Ertvelde, J.
    Boeckmans, J.
    Gatzios, A.
    Jover, R.
    Lindeman, B.
    Soop, G. Lopez
    Rodrigues, R. Marcelino
    Rapisarda, A.
    Stinckens, M.
    Sepehri, S.
    Vinken, M.
    Jiang, J.
    Vanhaecke, T.
    TOXICOLOGY LETTERS, 2023, 384 : S73 - S74
  • [3] PRACTICAL APPROACHES TO ADVERSE OUTCOME PATHWAY DEVELOPMENT AND WEIGHT-OF-EVIDENCE EVALUATION AS ILLUSTRATED BY ECOTOXICOLOGICAL CASE STUDIES
    Fay, Kellie A.
    Villeneuve, Daniel L.
    Lalone, Carlie A.
    Song, You
    Tollefsen, Knut Erik
    Ankley, Gerald T.
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2017, 36 (06) : 1429 - 1449
  • [4] Research on Adverse Outcome Pathway (AOP) Development For chemical-induced and life factor-induced liver Disease
    Choi, Hye-Yeon
    Lee, Yong-Hoon
    SAFETY AND HEALTH AT WORK, 2022, 13 : S223 - S224
  • [5] Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with Cyproconazole
    Luckert, Claudia
    Braeuning, Albert
    de Sousa, Georges
    Durinck, Sigrid
    Katsanou, Efrosini S.
    Konstantinidou, Parthena
    Machera, Kyriaki
    Milani, Emanuela S.
    Peijnenburg, Ad A. C. M.
    Rahmani, Roger
    Rajkovic, Andreja
    Rijkers, Deborah
    Spyropoulou, Anastasia
    Stamou, Marianna
    Stoopen, Geert
    Sturla, Shana
    Wollscheid, Bernd
    Zucchini-Pascal, Nathalie
    Lampen, Alfonso
    CHEMICAL RESEARCH IN TOXICOLOGY, 2018, 31 (08) : 784 - 798
  • [6] Employing an adverse outcome pathway framework for weight-of-evidence assessment with application to the ICH S1B guidance addendum
    Stalford, Susanne A.
    Cayley, Alex N.
    de Oliveira, Antonio Anax F.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2021, 127
  • [7] Optimization of an adverse outcome pathway network on chemical-induced cholestasis using an artificial intelligence-assisted data collection and confidence level quantification approach
    van Ertvelde, Jonas
    Verhoeven, Anouk
    Maerten, Amy
    Cooreman, Axelle
    Rodrigues, Bruna dos Santos
    Sanz-Serrano, Julen
    Mihajlovic, Milos
    Tripodi, Ignacio
    Teunis, Marc
    Jover, Ramiro
    Luechtefeld, Thomas
    Vanhaecke, Tamara
    Jiang, Jian
    Vinken, Mathieu
    JOURNAL OF BIOMEDICAL INFORMATICS, 2023, 145
  • [8] Adverse outcome pathway networks as the basis for the development of new approach methodologies: Liver toxicity as a case study
    Vinken, Mathieu
    CURRENT OPINION IN TOXICOLOGY, 2024, 40
  • [9] Applying the Key Characteristics Approach to Evaluate Mechanistic Evidence for Qualitative and Quantitative Weight of Evidence to Support Risk Assessment: A Case Study with Benzo[a]Pyrene-Induced Male Reproductive Toxicity
    Druwe, I
    Blake, B. E.
    Davis, A.
    Dean, J.
    Gibbons, C.
    Lambert, J.
    Lizarraga, L. L.
    Arzuaga, X.
    BIRTH DEFECTS RESEARCH, 2021, 113 (10): : 750 - 750